wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37702281-89DC52FA-F6A2-4A8F-A328-FF7B199EC9AA
Q37702281-89DC52FA-F6A2-4A8F-A328-FF7B199EC9AA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37702281-89DC52FA-F6A2-4A8F-A328-FF7B199EC9AA
Development of venetoclax for therapy of lymphoid malignancies.
P2860
Q37702281-89DC52FA-F6A2-4A8F-A328-FF7B199EC9AA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37702281-89DC52FA-F6A2-4A8F-A328-FF7B199EC9AA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ce2d584283cb26903056007ec3c39a6bd4d1a7e
P2860
MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies.